Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|142|6|1174-1181

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.142, Iss.6, 2018-03, pp. : 1174-1181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic syndrome in patients with myotonic dystrophy type 1

By  

MUSCLE AND NERVE, Vol. 52, Iss. 2, 2015-08 ,pp. : 273-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychological characteristics of patients with myotonic dystrophy type 1

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 1, 2015-07 ,pp. : 49-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Spontaneous chromosome loss and colcemid resistance in lymphocytes from patients with myotonic dystrophy type 1

By  

Cytogenetic and Genome Research, Vol. 100, Iss. 1-4, 2003-10 ,pp. : 224-229

Karger

Access to resources Recommend Favorite

A population‐based survey of risk for cancer in individuals diagnosed with myotonic dystrophy

By  

MUSCLE AND NERVE, Vol. 54, Iss. 4, 2016-10 ,pp. : 783-785

John Wiley & Sons Inc

Access to resources Recommend Favorite

Life habits in myotonic dystrophy type 1

By Gagnon Cynthia   Mathieu Jean   Noreau Luc  

Journal of Rehabilitation Medicine, Vol. 39, Iss. 7, 2007-09 ,pp. : 560-566

Medical Journals Limited

Access to resources Recommend Favorite